Could two doses of a common drug cut transfusions in hip fracture surgery?
NCT ID NCT07432737
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving two doses of tranexamic acid (a drug that helps blood clot) is better than one dose at reducing blood loss and the need for blood transfusions in older adults having hip fracture surgery. The trial includes 120 people aged 65 and older. Participants will receive either one dose before surgery or two doses (one before and one after). Researchers will track blood loss, transfusions, and safety for up to 90 days after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP FRACTURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Clinic PHI University Clinic for Surgical Diseases, St. Naum Ohridski
RECRUITINGSkopje, 1000, North Macedonia
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bone-Strengthening infusion given right after hip surgery prevent a second break?
- Home rehab after hip fracture: a new hope for independence?
- Could a simple education program be the key to better hip fracture recovery?
- Nerve block showdown: which eases hip fracture surgery pain best?
- Could a common bleeding drug cut transfusions after hip fractures?
- New french tool could help hip fracture patients walk again